MERGERS & ACQUISITIONS
and
STRATEGIC DUE DILIGENCE
EXPERTISE
New York | London
Chemicals
Ingredients
Materials
Industrial Minerals
Transactions
August/October 2025
Sale of assets of Cymer-Dayton LLC to PureTech Scientific
Iron Path Capital Portfolio Company
Sell-Side Advisor
Trumont serves as sell-side advisor to the shareholders of Cymer-Dayton LLC (Dayton, TN) in an asset sale transaction with
PureTech Scientific (Belle, WV)
Dayton, TN (USA) – Cymer-Dayton LLC has completed the sale of its assets to PureTech Scientific (a portfolio company of Iron Path Capital).
The assets acquired by PureTech have capabilities in specialty tolling and value-added services such as chemical processing development, chemical blending and formulation, chemical sample analysis and classification, organic synthesis, and pilot, scale-up programs.
PureTech was founded and backed by Iron Path Capital, a private equity firm specializing in lower-middle market investments across the specialty industrial and healthcare sectors.
The acquired assets will produce glycolic acid across several grades, expanding PureTech’s capabilities and enabling the company to purify its own products for high-purity applications.
Additionally, the site will be used to manufacture specialized products as well as serve other customers with their own chemical processing and manufacturing needs.
“This acquisition marks a significant step forward in our long-term growth strategy,” said PureTech CEO Jake Fitzgerald. “By integrating this facility and its talent into our business, we’re gaining strategic specialized capabilities and strengthening our position in the Life Sciences segment. We welcome the new team members and look forward to unlocking new value together.”
“This carve-out deal of an established business with strong fundamentals, untapped potential, and a clear path to accelerated growth represents exactly the type of opportunity we look for,” said Iron Path Capital Co-founder Scott Mraz. “We’re proud to support this next chapter for PureTech Scientific, investing in innovation, operational excellence, and long-term value creation.”
Born from a carve-out acquisition from The Chemours Company in 2023, PureTech was founded in 2023 by Iron Path with a vision for driving end-market growth through long-term investments in product innovation, high-touch customer support and a comprehensive organic and transformative growth strategy, including the infusion of technical expertise and resources in support of new customer-centered product applications, formulations and manufacturing capabilities.
For more information, visit puretechscientific.com.
August 29, 2025 (closed) / October 23, 2025 (announced)